独特型TCR Vβ2 DNA疫苗的构建和体外表达检测

目的:构建抗淋巴细胞白血病的独特型TCR Vβ2 DNA疫苗，并检测其转染K562细胞和体外表达情况。 方法:利用RT-PCR扩增表达TCR Vβ2的Molt-4细胞株的独特型TCR Vβ2基因片段，定向克隆于pIREs表达载体中，重组质粒转染至K562细胞中，利用间接免疫荧光法、SDS-PAGE和Western blotting等检测其表达情况。 结果:经PCR检测证实成功构建pIREs-TCR Vβ2重组子，转染至K562细胞后，利用Vβ2单抗可检测到K562细胞表面表达TCR Vβ2，SDS-PAGE分离检测为15 kD的蛋白质，并经Vβ2特异抗体Western blotting鉴定为TCR Vβ2蛋白。 结论:成功构建pIREs- TCR Vβ2 DNA疫苗，并可以在K562细胞株中表达特异蛋白。

Construction and expression analysis of idiotype TCR Vβ2 DNA vaccine in vitro

AIM:To develop an anti-lymphoblastic leukemia TCR idiotypic DNA vaccine, analyze its transfer activity into K562 cells and to detect its expression in vitro. METHODS:The TCR Vβ2 gene segment, which was identified from an idiotypic TCR Vβ2 clone-Molt4 cell line, was amplified using RT-PCR, and the PCR products were then cloned into pIRES vector. The recombinant plasmids were transferred into K562 cells. The condition of idiotypic protein expression was tested by indirect immunophenotyping fluorescein dyeing, SDS-PAGE and Western blotting. RESULTS:The recombinant DNA plasmid, pIRES-TCR Vβ2, was developed successfully. The expression of TCR Vβ2 was identified on the surface of K562 cells. A 15 kD protein, which bound to TCR Vβ2 antibody specifically, were identified from pIRES-TCR Vβ2 transfected K562 cells by Western blotting, indicating that TCR Vβ2 protein was expressed in vitro. CONCLUSION:The recombinant plasmid pIRES-TCR Vβ2 DNA vaccine was developed successfully, which was expressed TCR Vβ2 protein specifically in transfected K562 cells.